CYP19A1 Gene Aromatase Deficiency Genetic Test
At DNA Labs UAE, we offer the CYP19A1 Gene Aromatase Deficiency Genetic Test at a cost of AED 4400.0.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Reproductive Disorders
- Doctor: Gynecology
- Test Department: Genetics
Pre Test Information
Before undergoing the CYP19A1 Gene Aromatase Deficiency NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by CYP19A1 Gene Aromatase Deficiency.
Test Details
The CYP19A1 gene is responsible for encoding the enzyme aromatase, which converts androgens into estrogens. Aromatase deficiency is a rare genetic disorder characterized by a deficiency or absence of aromatase activity.
NGS (Next-Generation Sequencing) genetic testing is used to analyze multiple genes simultaneously. In the context of aromatase deficiency, NGS genetic testing can identify mutations or variations in the CYP19A1 gene that may be responsible for the condition.
NGS genetic testing for aromatase deficiency can be performed using a blood or saliva sample. The DNA is extracted and sequenced in a laboratory. Geneticists or genetic counselors then analyze the sequencing data to identify and interpret any variations or mutations in the CYP19A1 gene.
The results of NGS genetic testing for aromatase deficiency can provide valuable information for healthcare professionals and patients. It can confirm a diagnosis, guide treatment decisions, and provide information about the risk of passing the condition to future generations.
| Test Name | CYP19A1 Gene Aromatase deficiency Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Reproductive Disorders |
| Doctor | Gynecology |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CYP19A1 Gene Aromatase deficiency NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CYP19A1 Gene Aromatase deficiency NGS Genetic DNA Test gene CYP19A1 |
| Test Details | The CYP19A1 gene encodes the enzyme aromatase, which is responsible for the conversion of androgens (such as testosterone) into estrogens (such as estradiol). Aromatase deficiency is a rare genetic disorder characterized by a deficiency or absence of aromatase activity. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of aromatase deficiency, NGS genetic testing can be used to identify mutations or variations in the CYP19A1 gene that may be responsible for the condition. By analyzing the entire coding region of the CYP19A1 gene, NGS can provide a comprehensive assessment of genetic variations that may affect aromatase activity. This can help in diagnosing aromatase deficiency and identifying the specific genetic cause of the condition. NGS genetic testing for aromatase deficiency can be performed using a blood or saliva sample. The sample is sent to a laboratory where the DNA is extracted and sequenced. The sequencing data is then analyzed, and any variations or mutations in the CYP19A1 gene are identified and interpreted by geneticists or genetic counselors. The results of NGS genetic testing for aromatase deficiency can provide valuable information for healthcare professionals and patients. It can help in confirming a diagnosis, guiding treatment decisions, and providing information about the risk of passing the condition to future generations. |
